Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 6 (6) , 487-492
- https://doi.org/10.1007/s007760100002
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Hypovitaminosis D in a Sunny Country: Relation to Lifestyle and Bone MarkersJournal of Bone and Mineral Research, 2000
- Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in OsteoporosisJournal of Bone and Mineral Research, 2000
- Recurrence of Vertebral Fracture with Cyclical Etidronate Therapy in Osteoporosis: Histomorphometry and X-Ray Microanalysis EvaluationJournal of Bone and Mineral Research, 1999
- Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitroJournal of Bone and Mineral Research, 1993
- Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.Journal of Clinical Investigation, 1993
- Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosisJournal of Bone and Mineral Research, 1993
- The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: A randomized study comparing intermittent treatment and an ADFR regimeBone, 1991
- Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly womenJournal of Bone and Mineral Research, 1991
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Calcium-dependent .alpha.-helical structure in osteocalcinBiochemistry, 1982